Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

CG Oncology has the lowest figure of the 24 biotech companies ranked by cash on hand, at R$190M, followed by Adaptive Biotechnologies (R$412.3M) and ImmunityBio (R$516.6M). Figures as of 18 Nov 2026, 23:52 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
Lowest
CG OncologyR$190M
Median
R$2.5B
Combined market value
R$4.89T
Countries
5

Market values as of .

All countries
All sectors
Biotech
BRL
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↑Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health CareR$190MR$41.8BR$467.90 1.34% up 85% up United States
2Adaptive BiotechnologiesADPT · Health CareR$412.3MR$26.9BR$166.46 0.11% down 88% up United States
3ImmunityBioIBRX · Health CareR$516.6MR$41.7BR$39.19 7.03% up 193% up United States
4Halozyme TherapeuticsHALO · Health CareR$782.7MR$63.9BR$560.32 0.18% down 37% up United States
5VaxcytePCVX · Health CareR$1BR$54.2BR$342.27 1.48% down 22% up United States
6Twist BioscienceTWST · Health CareR$1.1BR$46.4BR$680.51 3.88% up 340% up United States
7Kodiak SciencesKOD · Health CareR$1.2BR$37.4BR$572.07 1.04% up 396% up United States
8Bio-TechneTECH · Health CareR$1.5BR$66.8BR$425.50 0.17% up 26% up United States
9Scholar Rock HoldingSRRK · Health CareR$1.9BR$34.3BR$280.74 6.48% up 14% up United States
10CRISPR TherapeuticsCRSP · Health CareR$2BR$22.8BR$235.06 0.10% up 21% down Switzerland
11Kymera TherapeuticsKYMR · Health CareR$2.1BR$60.5BR$708.47 0.32% down 87% up United States
12Revolution MedicinesRVMD · Health CareR$2.2BR$202.2BR$934.76 1.76% down 131% up United States
13ExelixisEXEL · Health CareR$2.8BR$97.5BR$399.41 0.31% down 63% up United States
14Krystal BiotechKRYS · Health CareR$2.9BR$54.7BR$1,844.36 5.62% up 46% up United States
15RepligenRGEN · Health CareR$3.3BR$64.6BR$1,009.91 6.47% up 5% up United States
16Neurocrine BiosciencesNBIX · Health CareR$4.2BR$96.4BR$952.54 1.84% down 20% up United States
17QiagenQGEN · Health CareR$4.9BR$59.9BR$289.87 0.38% down 12% up Netherlands
18ImmunovantIMVT · Health CareR$5.3BR$40.1BR$194.00 0.12% down 43% up United States
19ModernaMRNA · Health CareR$15.2BR$465.7BR$1,150.99 4.84% down 755% up United States
20BiogenBIIB · Health CareR$17.6BR$217.4BR$1,470.45 0.25% up 49% up United States
21argenxARGX · Health CareR$20.4BR$346.2BR$5,505.18 0.66% down 4% up Belgium
22Gilead SciencesGILD · Health CareR$44.2BR$1.23TR$988.33 0.75% down 33% up United States
23BioNTechBNTX · Health CareR$49.8BR$120.7BR$486.97 1.89% down 16% down Germany
24AmgenAMGN · Health CareR$53.4BR$1.4TR$2,596.22 3.07% down 34% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 5.8488 BRL).

Questions and answers

Which biotech companies have the lowest cash on hand?

CG Oncology (R$190M), Adaptive Biotechnologies (R$412.3M) and ImmunityBio (R$516.6M) have the lowest cash on hand of the 24 biotech companies ranked here as of 18 Nov 2026, 23:52 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of R$4.89T as of 18 Nov 2026, 23:52 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.